Le Lézard

News by subject: Conference

29 may 2020

17:07
PTC today announced that management will participate in the following virtual conferences this summer. What:   Baird 2020 Global Consumer, Technology & Services Conference When:   Thursday, June 4th, 2020 at 9:05am ET      ...

16:35
Creatv MicroTech, a privately-held biotechnology company has pioneered a blood test for the universal screening of early stage cancer. They will present their initial clinical data showing the ability to identify invasive cancer with 87% accuracy....

15:00
Acadia Healthcare Company, Inc. today announced that the Company will participate in the Jefferies Virtual Global Healthcare Conference 2020, which takes place June 2 ? 4, 2020. There will be an on-line webcast of the Company's presentation...

14:05
Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced that Chris Peetz, president and chief executive officer at Mirum will...

13:05
Flex announced today that it will participate in the following investor conference virtually: 2020 Bank of America Global Technology Conference Date: June 4, 2020 Presentation time: 10am PT / 1:00pm ET A live webcast and replay of the event...

12:30
Odonate Therapeutics, Inc. , a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June...

12:15
Updated clinical data for Vitrakvi® (larotrectinib) show continued high response rates and duration of response with longer follow-up and consistent safety in an expanded data set of 116 adult patients with tropomyosin receptor kinase (TRK) fusion...

12:07
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the presentation of positive...

12:05
Foundation Medicine, Inc. and Dana-Farber Cancer Institute presented new data highlighting the utility of comprehensive genomic profiling (CGP) to guide treatment decisions in patients with advanced non-small cell lung cancer (NSCLC) whose tumors...

12:02
RGENIX, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today it is presenting data showing clinical activity in patients with advanced colorectal (CRC) tumors from...

12:01
Syros Pharmaceuticals , a leader in the development of medicines that control the expression of genes, today announced new preclinical data for SY-5609, its highly selective and potent oral inhibitor of cyclin-dependent kinase 7 (CDK7). The data show...

12:00
Deciphera Pharmaceuticals, Inc. today announced the presentation of quality of life and certain safety results from the INVICTUS pivotal Phase 3 study evaluating QINLOCKtm (ripretinib) in adult patients with fourth-line advanced gastrointestinal...

12:00
Detailed results from the positive registrational, randomized controlled Phase II DESTINY-Gastric01 trial showed AstraZeneca and Daiichi Sankyo Company, Limited's (Daiichi Sankyo) ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a...

12:00
CrowdStrike Holdings, Inc. today announced that George Kurtz, co-founder and chief executive officer, and Burt Podbere, chief financial officer, are scheduled to present at the following virtual investor conferences: Bank of America 2020 Global...

12:00
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced the results of the Phase 2 Pevonedistat-2001 trial will be presented during oral sessions at the virtual 56th American Society of Clinical Oncology (ASCO) Annual Meeting and...

12:00
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced that the company will present two posters at the EULAR 2020...

12:00
Kite, a Gilead Company , today announced results from an interim analysis of ZUMA-5, a global, multicenter, single-arm, open-label Phase 2 study evaluating Yescarta® (axicabtagene ciloleucel) in adult patients with relapsed or refractory indolent...

12:00
Schwazze, formerly operating as Medicine Man Technologies, Inc. ("Schwazze" or "the Company"), announced today that it will be participating in two upcoming virtual investor conferences. Benzinga Virtual Cannabis Capital Conference Mr. Justin Dye,...

12:00
Incyte today announced that data from the interim analysis of the Phase 2 OPTIC (Optimizing Ponatinib Treatment In CML) trial, which was sponsored by Takeda and co-funded by Incyte, will be presented during an oral session at the upcoming 2020...

12:00
Arcos Dorados Holdings Inc. ("Arcos Dorados" or the "Company"), Latin America's largest restaurant chain and the world's largest independent McDonald's franchisee, today announced that it will participate in the following upcoming investor...

12:00
Silverback Therapeutics ("Silverback"), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered, but locally active, today announced that preclinical data for its lead ImmunoTACtm candidate, SBT6050, will be...

12:00
Results from the ongoing Phase II DESTINY-Lung01 trial showed AstraZeneca and Daiichi Sankyo Company, Limited's (Daiichi Sankyo) ENHERTU® (fam-trastuzumab deruxtecan-nxki) achieved a clinically meaningful tumor response in patients with HER2-mutant...

12:00
Detailed results from the positive pivotal randomized, controlled phase 2 DESTINY-Gastric01 trial showed Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca's ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a...

12:00
Results from the phase 2 DESTINY-CRC01 trial of Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca's ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful activity in patients with HER2 positive...

12:00
Okta, Inc. , the leading independent provider of identity for the enterprise, today announced that members of its management team are scheduled to participate in upcoming investor conferences. Details for each event are as follows: Bank of America...

11:00
J2 Global, Inc. , a leading Internet information and services company, today announced its participation in six investor conferences in June. Details of the conferences are as follows: Baird 2020 Virtual Global Consumer, Technology & Services...

11:00
AVEO Oncology today announced the presentation of results from the final analysis of overall survival (OS) in its pivotal Phase 3 TIVO-3 trial comparing tivozanib, the Company's next-generation vascular endothelial growth factor (VEGF) receptor...

10:30
Ares Management Corporation announced today that Michael Arougheti, its Chief Executive Officer and President, and Michael McFerran, its Chief Operating Officer and Chief Financial Officer, are scheduled to present at the Morgan Stanley Virtual U.S....

10:30
Telenav®, Inc. , a leading provider of connected car and location-based products and services, today announced that its management team will participate in the 4th Annual Needham Virtual Automotive Tech Conference on Wednesday, June 3. Adeel...

10:00
Boundless Bio, a company interrogating and targeting extrachromosomal DNA (ecDNA) in aggressive cancers, today will present data at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting that highlight ecDNA's relationship with...

09:00
MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced today top line results from the Phase Ib dose escalation and cohort expansion study, OUTREACH, of lead candidate MTL-CEBPA in combination with sorafenib standard of care in...


28 may 2020

22:37
Merck , known as MSD outside the United States and Canada, and Eisai today announced new data from analyses of two trials evaluating KEYTRUDA, Merck's anti-PD-1 therapy, plus LENVIMA, an orally available multiple receptor tyrosine kinase inhibitor...

22:19
Pinterest, Inc. today announced that Todd Morgenfeld, Chief Financial Officer, will participate at the BofA Securities 2020 Global Technology Conference on June 4, 2020 at 8:30 am PT (11:30 am ET). A live webcast and replay of the presentation...

21:16
Intercontinental Exchange, Inc. , a leading operator of global exchanges and clearing houses and provider of data and listings services, announced today that Jeffrey C. Sprecher, Chairman and CEO, will present at the Piper Sandler Global Exchange and...

21:00
Chewy, Inc. ("Chewy"), a trusted online destination for pet parents, today announced that Sumit Singh, Chief Executive Officer and Director, and Mario Marte, Chief Financial Officer, will virtually present at the William Blair 40th Annual Growth...

20:33
Impac Mortgage Holdings, Inc. (the "Company") today announced that its Board of Directors has approved a change in the location of its 2020 Annual Meeting of Stockholders to a virtual-only stockholder meeting. Due to the ongoing public health impact...

20:30
FIStm , a global leader in financial services technology, will present on Tue., June 2, 2020, at the BofA Securities 2020 Global Technology Conference at 11:30 a.m. (EDT); Wed., June 3, 2020, at the Baird's 2020 Global Consumer, Technology & Services...

20:30
Black Stone Minerals, L.P. ("Black Stone Minerals," "BSM," or "the Company") today announced its participation in two upcoming investor relations events. Members of management will be participating in the following: 2020 RBC Capital Markets...

20:15
Avalara, Inc. , a leading provider of tax compliance automation for businesses of all sizes, today announced the following upcoming virtual investor conference presentations. Co-Founder and Chief Executive Officer Scott McFarlane will present at:...

20:15
May 28, 2020 ? Triton International Limited today announced that Brian Sondey, Chairman and Chief Executive Officer, will be presenting at the UBS Global Industrials and Transportation Virtual Conference on Tuesday, June 2, 2020 at 10:00 a.m....

20:15
Fabrinet , a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced that its management will present at...

20:10
AdaptHealth Corp. ("AdaptHealth"), a leading provider of home medical equipment, supplies and related services in the United States, today announced that the Company is scheduled to present at the Jefferies Virtual Healthcare Conference on Thursday,...

20:05
Shake Shack Inc. ("Shake Shack" or the "Company") , today announced that the Company will be participating in the following virtual investor conferences in June: On Thursday, June 4, 2020, the Company will participate in a panel and hold investor...

20:05
Keysight Technologies, Inc. , a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world, announced today participation in the following upcoming virtual event with the...

20:03
Orthofix Medical Inc. today announced that President and Chief Executive Officer Jon Serbousek will present at the Jefferies 2020 Healthcare Conference on Tuesday, June 2, 2020 at 3:00 p.m. ET. The conference will be held in a virtual meeting...

20:01
NetApp , the leader in cloud data services, today announced that Kris Newton, vice president, investor relations, will participate in a fireside chat at the Bank of America Securities Technology Conference on June 2, 2020 at 1:00 p.m. Pacific Time....

20:01
Insulet Corporation (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two upcoming virtual investor conferences: The Piper Sandler...

20:00
Alex Chriss, executive vice president and general manager of Intuit's Small Business & Self-Employed Group, will participate in a fireside chat at the virtual Bank of America 2020 Global Technology Conference, on Wednesday, June 3. The fireside...

18:54
Today, Sarah Cannon announced that it will present its latest cancer research insights at the American Society of Clinical Oncology's (ASCO®) Annual Meeting being held virtually May 29 ? 31, 2020. This year, Sarah Cannon's drug development and...

15:45
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced that members of...